Q4 2024 Earnings Conference Call March 14, 2025 8:00 AM ETCompany ParticipantsAndrew Posen - Vice President and Head, ...

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets ...

Thermo Fisher is among the industry's best when it comes to cost control. As near-term spending is constrained, the company's margins show exceptional resilience. As of fiscal year-end 2024, Thermo ...

The move comes as Tampa, Fla.-based ConnectWise is looking to fully integrate all of its offerings into the Asio platform or ...

REX Shares debuted an ETF providing exposure to Strategy’s convertible bonds, a form of debt that was hard to access for most ...

This access control is an example of a highly fragmented industry, where one-size-fits-all solutions rarely succeed. With ...

As the technology continues to evolve, the key differentiator will be how companies use these tools to create value for both ...

Strategy has yet to buy the latest Bitcoin dip, possibly signaling its approach to acquiring BTC is shifting alongside market ...

Discover how hyper-premium and personalised chocolate trends are redefining confectionery, blending luxury, exclusivity, and ...

Fixed income traders now have access to abundant pricing data. We explore how traders can navigate the vast amount of quote data available and use it effectively in their decision-making processes.

VCI Global is making strategic moves to strengthen its operational footprint and diversify revenue streams. In April 2025, the Company will establish offices in Hong Kong, Singapore, and Indonesia, ...

Whether it's through groundbreaking new uses or by solving persistent problems, new product categories are all about making life easier and more efficient for customers.